← Open Payments lookup

JAMIE BELGARD: Open Payments

NPI 1396186482 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$882 in 31 payments from 10 companies in 2025. Trend: 2023 $973 · 2024 $1,039 · 2025 $882

Food & beverage: $882
CompanyPaymentsAmount
Axsome Therapeutics, Inc.3$259
ABBVIE INC.11$155
Janssen Pharmaceuticals, Inc1$124
Otsuka America Pharmaceutical, Inc.5$103
Neurocrine BioSciences, Inc.4$95
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$55
Alkermes, Inc.2$34
Lundbeck LLC1$20
E.R. Squibb & Sons, L.L.C.1$19
Braeburn Inc.1$19

Products named: Auvelity, VRAYLAR, INVEGA SUSTENNA, REXULTI, INGREZZA, CAPLYTA, ABILIFY ASIMTUFII, ARISTADA.

Industry payments across LA — which companies pay providers there.